loadpatents
name:-0.052096128463745
name:-0.049827098846436
name:-0.0068759918212891
Petersen; John S. Patent Filings

Petersen; John S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Petersen; John S..The latest application filed is for "polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof".

Company Profile
4.54.50
  • Petersen; John S. - Acton MA
  • Petersen; John S. - Austin TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
MetAP2 inhibitors and methods of treating obesity
Grant 11,304,944 - Petersen , et al. April 19, 2
2022-04-19
Polymer-conjugated Metap2 Inhibitors, And Therapeutic Methods Of Use Thereof
App 20210128607 - PETERSEN; John S.
2021-05-06
Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof
Grant 10,722,532 - Petersen
2020-07-28
Metap2 Inhibitors And Methods Of Treating Obesity
App 20200155545 - PETERSEN; John S. ;   et al.
2020-05-21
METAP2 inhibitors and methods of treating obesity
Grant 10,588,904 - Petersen , et al.
2020-03-17
Polymer-conjugated Metap2 Inhibitors, And Therapeutic Methods Of Use Thereof
App 20190151353 - PETERSEN; John S.
2019-05-23
Fumagillol derivatives and polymorphs thereof
Grant 10,287,277 - Petersen
2019-05-14
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
Grant 10,159,692 - Petersen Dec
2018-12-25
Fumagillol Derivatives And Polymorphs Thereof
App 20180291010 - Petersen; John S.
2018-10-11
Metap2 Inhibitors And Methods Of Treating Obesity
App 20180271856 - Petersen; John S. ;   et al.
2018-09-27
METAP2 inhibitors and methods of treating obesity
Grant 10,010,544 - Petersen , et al. July 3, 2
2018-07-03
Fumagillol derivatives and polymorphs thereof
Grant 9,969,722 - Petersen May 15, 2
2018-05-15
Direct compression polymer tablet core
Grant 9,931,358 - Tyler , et al. April 3, 2
2018-04-03
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
Grant 9,895,449 - Petersen February 20, 2
2018-02-20
Polymer-conjugated Metap2 Inhibitors, And Therapeutic Methods Of Use Thereof
App 20180008630 - Petersen; John S.
2018-01-11
Metap2 Inhibitors And Methods Of Treating Obesity
App 20170326135 - Petersen; John S. ;   et al.
2017-11-16
Polymer-conjugated Metap2 Inhibitors, And Therapeutic Methods Of Use Thereof
App 20170258925 - Petersen; John S.
2017-09-14
MetAP2 inhibitors and methods of treating obesity
Grant 9,757,373 - Petersen , et al. September 12, 2
2017-09-12
METAP2 inhibitors and methods of treating obesity
Grant 9,750,737 - Petersen , et al. September 5, 2
2017-09-05
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
Grant 9,730,955 - Petersen August 15, 2
2017-08-15
Direct Compression Polymer Tablet Core
App 20170202872 - Tyler; Joseph ;   et al.
2017-07-20
Fumagillol Derivatives And Polymorphs Thereof
App 20170166556 - Petersen; John S.
2017-06-15
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
Grant 9,585,909 - Petersen March 7, 2
2017-03-07
Direct compression polymer tablet core
Grant 9,579,343 - Tyler , et al. February 28, 2
2017-02-28
Metap2 Inhibitors And Methods Of Treating Obesity
App 20170028014 - Petersen; John S. ;   et al.
2017-02-02
Metap2 Inhibitors And Methods Of Treating Obesity
App 20160346244 - Petersen; John S. ;   et al.
2016-12-01
Polymer-conjugated Metap2 Inhibitors, And Therapeutic Methods Of Use Thereof
App 20160256483 - Petersen; John S.
2016-09-08
METAP2 inhibitors and methods of treating obesity
Grant 9,433,600 - Petersen , et al. September 6, 2
2016-09-06
Polymer-conjugated Metap2 Inhibitors, And Therapeutic Methods Of Use Thereof
App 20160184345 - Petersen; John S.
2016-06-30
Apparatus and method of direct writing with photons beyond the diffraction limit using two-color resist
Grant 9,329,484 - Markle , et al. May 3, 2
2016-05-03
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
Grant 9,320,805 - Petersen April 26, 2
2016-04-26
Apparatus And Method Of Direct Writing With Photons Beyond The Diffraction Limit Using Two-color Resist
App 20160103394 - Markle; David A. ;   et al.
2016-04-14
Apparatus and method of direct writing with photons beyond the diffraction limit
Grant 9,304,410 - Markle , et al. April 5, 2
2016-04-05
Metap2 Inhibitors And Methods Of Treating Obesity
App 20150374657 - Petersen; John S. ;   et al.
2015-12-31
Apparatus and method of direct writing with photons beyond the diffraction limit using two-color resist
Grant 9,195,139 - Markle , et al. November 24, 2
2015-11-24
Apparatus and method of direct writing with photons beyond the diffraction limit
App 20150331330 - Markle; David A. ;   et al.
2015-11-19
METAP2 inhibitors and methods of treating obesity
Grant 9,173,956 - Petersen , et al. November 3, 2
2015-11-03
Apparatus and methods for microscopy having resolution beyond the Abbe limit
Grant 9,075,013 - Markle , et al. July 7, 2
2015-07-07
Apparatus and method of direct writing with photons beyond the diffraction limit using two-color resist
App 20150185617 - Markle; David A. ;   et al.
2015-07-02
Optimized Drug Conjugates
App 20150141580 - Petersen; John S.
2015-05-21
Direct Compression Polymer Tablet Core
App 20150056278 - Tyler; Joseph ;   et al.
2015-02-26
METAP2 Inhibitors and Methods of Treating Obesity
App 20140308235 - Petersen; John S. ;   et al.
2014-10-16
Method of direct writing with photons beyond the diffraction limit
Grant 8,642,232 - Markle , et al. February 4, 2
2014-02-04
Apparatus and methods for microscopy having resolution beyond the Abbe limit
App 20130286179 - Markle; David A. ;   et al.
2013-10-31
Polymer-Conjugated MetAP2 inhibitors, and Therapeutic Methods of Use Thereof
App 20130216494 - Petersen; John S.
2013-08-22
Optimized Drug Conjugates
App 20130137831 - Petersen; John S.
2013-05-30
Apparatus and method of direct writing with photons beyond the diffraction limit
App 20130130182 - Markle; David A. ;   et al.
2013-05-23
Low salt forms of polyallylamine
Grant 8,377,428 - Petersen , et al. February 19, 2
2013-02-19
Direct Compression Polymer Tablet Core
App 20120322894 - Tyler; Joseph ;   et al.
2012-12-20
Combination cartridge and device for electrokinetic delivery of medicament to a treatment site
Grant 8,321,008 - Petersen , et al. November 27, 2
2012-11-27
Direct compression polymer tablet core
Grant 8,187,631 - Tyler , et al. May 29, 2
2012-05-29
Optimized Drug Conjugates
App 20110294952 - Petersen; John S.
2011-12-01
Combination therapy for treating hypercholesterolemia
App 20100266526 - Huval; Chad Cori ;   et al.
2010-10-21
Low Salt Forms of Polyallylamine
App 20100068167 - Petersen; John S. ;   et al.
2010-03-18
Combination therapy for treating hypercholesterolemia
Grant 7,638,524 - Huval , et al. December 29, 2
2009-12-29
Direct compression polymer tablet core
App 20090291135 - Tyler; Joseph ;   et al.
2009-11-26
Low salt forms of polyallylamine
Grant 7,541,024 - Petersen , et al. June 2, 2
2009-06-02
Resolution Enhancement Techniques Combining Interference-assisted Lithography With Other Photolithography Techniques
App 20090117491 - Hendel; Rudolf ;   et al.
2009-05-07
Resolution Enhancement Techniques Combining Four Beam Interference-assisted Lithography With Other Photolithography Techniques
App 20090111056 - Hendel; Rudolf ;   et al.
2009-04-30
Applicator Cartridge For An Electrokinetic Delivery System For Self Administration Of Medicaments
App 20080051692 - Petersen; John S. ;   et al.
2008-02-28
Optical proximity correction
Grant RE40,084 - Petersen , et al. February 19, 2
2008-02-19
Combination Cartridge And Device For Electrokinetic Delivery Of Medicament To A Treatment Site
App 20070233048 - Petersen; John S. ;   et al.
2007-10-04
Poly(diallylamine)-based bile acid sequestrants
App 20070190021 - Holmes-Farley; Stephen Randall ;   et al.
2007-08-16
Electrokinetic System And Method For Delivering Methotrexate
App 20070185432 - Etheredge; Robert W. III ;   et al.
2007-08-09
Poly(diallylamine)-based bile acid sequestrants
Grant 7,125,547 - Holmes-Farley , et al. October 24, 2
2006-10-24
Direct compression polymer tablet core
App 20060034914 - Tyler; Joseph ;   et al.
2006-02-16
Direct compression polymer tablet core
App 20050260236 - Tyler, Joseph ;   et al.
2005-11-24
Method for phase shift mask design, fabrication, and use
Grant 6,800,401 - Petersen October 5, 2
2004-10-05
Direct compression polymer tablet core
App 20040166156 - Tyler, Joseph ;   et al.
2004-08-26
Poly(diallylamine)-based bile acid sequestrants
App 20040151687 - Holmes-Farley, Stephen Randall ;   et al.
2004-08-05
Direct compression polymer tablet core
Grant 6,733,780 - Tyler , et al. May 11, 2
2004-05-11
Poly(diallylamine)-based bile acid sequestrants
Grant 6,610,283 - Holmes-Farley , et al. August 26, 2
2003-08-26
Projection imaging system with a non-circular aperture and a method thereof
Grant 6,556,361 - Smith , et al. April 29, 2
2003-04-29
Optical proximity correction
Grant 6,541,167 - Petersen , et al. April 1, 2
2003-04-01
Low salt forms of polyallylamine
App 20020159968 - Petersen, John S. ;   et al.
2002-10-31
Combination therapy for treating hypercholesterolemia
App 20020155091 - Huval, Chad Cori ;   et al.
2002-10-24
Imaging method using phase boundary masking with modified illumination
Grant 6,388,736 - Smith , et al. May 14, 2
2002-05-14
Direct compression polymer tablet core
App 20020054903 - Tyler, Joseph ;   et al.
2002-05-09
Combination therapy for treating hypercholesterolemia
Grant 6,365,186 - Huval , et al. April 2, 2
2002-04-02
Method for phase shift mask design, fabrication, and use
App 20020015900 - Petersen, John S.
2002-02-07
Optical proximity correction
App 20020001758 - Petersen, John S. ;   et al.
2002-01-03
System and method of providing optical proximity correction for features using phase-shifted halftone transparent/semi-transparent features
Grant 6,335,130 - Chen , et al. January 1, 2
2002-01-01
Polymers containing guanidinium groups as bile acid sequestrants
Grant 6,294,163 - Dhal , et al. September 25, 2
2001-09-25
Combination therapy for treating hypercholestrolemia
Grant 6,264,938 - Huval , et al. July 24, 2
2001-07-24
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
Grant 6,248,318 - Huval , et al. June 19, 2
2001-06-19
Poly(diallylamine)-based bile acid sequestrants
Grant 6,203,785 - Holmes-Farley , et al. March 20, 2
2001-03-20
Polyvalent polymers for the treatment of rotavirus infection
Grant 6,187,762 - Mandeville, III , et al. February 13, 2
2001-02-13
Chiral surfactants and methods for their use in chiral separations
Grant 6,090,250 - Mazzeo , et al. July 18, 2
2000-07-18
Hydrophobic sequestrant for cholesterol depletion
Grant 5,969,090 - Mandeville, III , et al. October 19, 1
1999-10-19
Polyvalent polymers for the treatment of rotavirus infection
Grant 5,891,862 - Mandeville, III , et al. April 6, 1
1999-04-06
Antireflective coating process
Grant 5,635,333 - Petersen , et al. June 3, 1
1997-06-03
Hydrophobic amine polymer sequestrant and method of cholesterol depletion
Grant 5,618,530 - Mandeville, III , et al. April 8, 1
1997-04-08
Liquid chromatography stationary phases with reduced silanol interactions
Grant 5,374,755 - Neue , et al. December 20, 1
1994-12-20
Process for effecting high efficiency separations by capillary electrophoresis
Grant 5,192,405 - Petersen , et al. March 9, 1
1993-03-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed